Onexton Gel clindamycin phosphate/benzoyl peroxide regulatory update

FDA approved Onexton Gel clindamycin phosphate/benzoyl peroxide from Valeant to treat acne vulgaris in patients ages =12 years. Valeant said it plans to launch the fixed combination of 1.2% clindamyci...